all Amy Wagers stories

Three Harvard teams to receive $9 million each in federal funding for stem cell research

404132862 — Thu, 08 Oct 2009 10:11:45 -0400

Three teams of Harvard Stem Cell Institute (HSCI) researchers are slated to receive $27 million over seven years in National Heart Lung and Blood Institute (NHLBI) grants for the development of stem-cell based tools and treatments to understand and treat cardiovascular and blood disorders. The NHLBI Progenitor Cell Biology Consortium will consist of nine research hubs, each involving multidiscplinary teams from two academic medical centers.

Safer stem cells for therapy

50443248 — Thu, 25 Jun 2009 13:20:53 -0400

When stem cell researchers in Japan and the United States announced in 2007 that they had developed long-sought methods to return fully developed adult human cells to an embryonic-like state, the world of stem cell research was turned upside down.

Five at Harvard named HHMI Early Career Scientists;

404132862 — Thu, 26 Mar 2009 06:00:15 -0400

Five Harvard scientists are among 50 young scientists nationwide who will have their work supported for the next six years by a new initiative from the Howard Hughes Medical Institute (HHMI).

HHMI today announced that the selected scientists are at 33 institutions across the United States and have led their own laboratories for two to six years. An HHMI statement described the young researchers as “energetic and passionate about a broad range of scientific questions… at a career stage that many consider to be a scientist’s most productive — and most vulnerable.”

NIH names Harvard Pioneers, Innovators

404132862 — Mon, 22 Sep 2008 16:25:41 -0400

Harvard faculty members comprise almost 20 percent of the 47 scientists nationally whose promising and innovative work was today recognized with the announcement of two grant programs through the National Institutes of Health (NIH).

The grants, expected to total $138 million over five years for all recipients, recognize established researchers through the Pioneer Award and young scientists through the New Innovator Award.

The awards support potentially high-impact research whose approaches have the potential to transform biomedical and behavioral science.

GlaxoSmithKline and Harvard Stem Cell Institute announce major collaboration agreement

404132862 — Mon, 21 Jul 2008 15:00:05 -0400

GlaxoSmithKline (GSK) and the Harvard Stem Cell Institute (HSCI) today announced that they have entered into a five-year, $25 million-plus collaborative agreement to build a unique alliance in stem cell science to hasten the development of treatments and cures for a range of diseases.

Stem cells used to treat muscular dystrophy in mice

404132862 — Fri, 11 Jul 2008 10:45:11 -0400

Harvard Stem Cell Institute researchers at the Joslin Diabetes Center have for the first time demonstrated that transplanted muscle stem cells can both improve muscle function in mice with a form of muscular dystrophy and replenish the stem cell population for use in the repair of future muscle injuries.

Amy Wagers - focusing on stem cell biology

404132862 — Fri, 11 Jul 2008 09:45:39 -0400

Twenty minutes after her weekly lab meeting is scheduled to begin, Amy Wagers rushes into a conference room on the fourth floor of the Joslin Diabetes Center, where her lab team sits, chatting around a long oval table.

“Sorry I’m late,” she calls out, closing the door behind her. “Oh good, the food’s here!"

Grabbing half a sandwich and a pickle off a catered tray, she simultaneously grabs a seat and motions for her team to begin its presentations. Lights out.

In the darkened room, all eyes turn to the illuminated white screen. There, in all its monochromic splendor, glows an enlarged image of a blood-forming hematopoietic stem cell.